USPTO Finds Blood-Collecting Device Patent Invalid
The USPTO on Aug. 2, 2005 granted a reexamination for seven claims on one of HemoCue’s patents in a hematology patent battle between the Boerne, Texas-based Stanbio Laboratory LP and Swedish medical diagnostic products maker HemoCue.
The USPTO rejected all claims in its initial conclusion, invalidating the patent, Stanbio said on...
Already a subscriber? Click here to login